CDC Nutrition Biomarkers offer a useful, but limited, window into nutritional health in the United States. The 2026 CDC National Nutrition Report used NHANES data collected from 1999 through August 2023 and analyzed 131 biochemical indicators in blood or urine from a representative U.S. population sample, according to the CDC’s 2026 report release on June 24, 2026 CDC nutrition report.
For wellness readers, the report is not a set of personal instructions. It does not say that every person needs the same foods, supplements, lab tests, or clinical follow-up. Nutrient needs can differ by age, pregnancy status, health conditions, medication use, dietary pattern, and access to care. What the report can do is show population patterns that may help clinicians, public health agencies, and communities ask better questions about nutrition risk and nutrition excess.
What CDC Nutrition Biomarkers Measure
CDC Nutrition Biomarkers In Context
CDC Nutrition Biomarkers are biochemical measures found in blood or urine. They can reflect nutrient status more directly than diet surveys alone, although they still require careful interpretation. A person’s biomarker level can be influenced by recent intake, long-term eating patterns, supplements, inflammation, kidney function, genetics, and other health factors. That is why these findings are best read as public health signals, not as a substitute for individualized medical assessment.
The report is especially valuable because several nutrient markers have been tracked across more than two decades. Folate, vitamin D, iron, and iodine have been measured nearly continuously, allowing researchers to compare broad trends rather than relying on isolated snapshots. Long-running measurement can help identify whether a national pattern is improving, worsening, or remaining fairly stable.
What The Report Can And Cannot Tell Us
The report can show that certain nutrient markers changed over time. It can also show that some groups had lower or higher biomarker concentrations than others. It cannot explain every reason behind those patterns. For example, a population-level increase in vitamin D biomarker levels may relate to supplement use, food patterns, sun exposure, fortification, or other factors. The report can suggest areas for closer study, but it should not be used to diagnose individuals.
Readers interested in public health reporting within the same network should consider exploring more on wellness and community well-being at Daily California.
Signals In Folate, Vitamin D, Iron, And Iodine
Folate And Fortification
Folate findings show both progress and caution. Mandatory folic acid fortification of enriched cereal grain products began in 1998. The research notes report that folate deficiency or insufficiency among women of reproductive age once affected about 10% to 12% of that group, while recent cycles show it at less than 1%. That suggests fortification has been associated with substantial gains at the population level.
At the same time, mean serum folate, red blood cell folate, and urine iodine concentrations have decreased by about 10% to 30% since the early 2000s. That does not erase the benefits seen after folic acid fortification. It does suggest that favorable averages can coexist with downward trends that deserve monitoring, especially in groups with higher nutritional vulnerability.
Vitamin D, Iron, And Iodine Patterns
Vitamin D shows a different pattern. Mean serum 25-hydroxyvitamin D concentrations increased by roughly 20% since the early 2000s. Yet deficiency in vitamins B12, D, and E changed only minimally over time, according to the research notes. This distinction matters: a higher average does not necessarily mean deficiency has disappeared, and it may not affect every group equally.
Iron is a particular concern for women of reproductive age in the recent cycles described in the research. The prevalence of iron deficiency rose by nearly 6 percentage points in that group. Folate insufficiency also rose by nearly 6 percentage points in women of reproductive age in recent cycles, even though the longer-term fortification story remains positive. Those parallel findings are a reminder that public health success can require continued surveillance rather than one-time policy action.
Supplement Use And Safety Signals
Higher Biomarkers Do Not Always Mean Better
Supplement use appears strongly associated with higher nutrient biomarker levels. In 2017 through March 2020, about 35% of children and adolescents and about 60% of adults reported taking at least one dietary supplement in the past 30 days. The research notes state that supplement users generally had better nutrient biomarker profiles than nonusers.
That finding should be interpreted with care. “Better” at a population level does not mean every supplement is useful for every person. It also does not mean more is always safer. Excess vitamin D, defined in people ages 6 and older as higher-than-recommended levels, increased from less than 1% to about 8% of the U.S. population. The highest excess levels were reported among adult supplement users, women, and non-Hispanic White persons.
Why Supplement Decisions Need Individual Context
CDC Nutrition Biomarkers can help identify population patterns, but supplement decisions can be personal and clinically specific. Vitamin D, iron, iodine, folate, and B12 needs may vary for people who are pregnant, taking certain medications, following restricted diets, living with chronic conditions, or managing absorption concerns. This article is educational and does not replace medical advice.
A cautious wellness approach avoids both extremes: assuming supplements are always needed and assuming supplements are always unnecessary. The report suggests that supplement use may contribute to higher levels for some nutrients, while also showing that excess vitamin D has become more common. Both ideas can be true at once.
Omega-3 And New Nutrition Markers
Omega-3 Status As A Public Health Question
One of the stronger shortfall signals in the research notes involves omega-3 status. More than 50% of the U.S. population had an undesirable omega-3 index, and about 98% fell below optimal levels, defined as an omega-3 index below 8% for EPA plus DHA in red blood cell fatty acids. This does not mean a single food, supplement, or diet pattern is appropriate for everyone. It does suggest that fatty acid status may merit more public health attention.
Omega-3 measures are useful because they reflect biological status rather than self-reported intake alone. Still, interpretation should remain cautious. The report identifies a population pattern; it does not specify an individualized intake target, clinical treatment plan, or supplement recommendation for each reader.
New Indicators Expand The Evidence Base
The report also includes indicators that were not previously measured in this national reporting structure. These include a combined B12 status indicator called 3cB12, which combines serum or plasma B12, methylmalonic acid, and homocysteine; the omega-3 index in red blood cells; trace elements such as copper and zinc; several fatty acid markers; 15 caffeine metabolites; several trans-fatty acids; and acrylamide adducts. A peer-reviewed overview notes these new indicators and discusses demographic differences in biomarker concentrations PMC report overview.
Adding markers does not automatically answer every nutrition question. It does provide more ways to evaluate population-level exposures and nutrient status. Over time, that may help public health researchers see which patterns are stable, which are changing, and which groups may need more focused attention.
Equity And Public Health Questions
Disparities Require Careful Interpretation
The research notes state that non-Hispanic Black and Hispanic populations often had lower biomarker concentrations relative to non-Hispanic White populations. Some age and life-stage groups, including women of childbearing age, also showed higher risk for certain deficiencies. These differences should not be framed as individual failure. Nutrition status can reflect food access, income, housing, healthcare access, cultural food patterns, supplement access, environmental exposure, and policy conditions.
Equity-focused interpretation asks what systems shape nutritional opportunity. A biomarker gap may point toward barriers that cannot be solved by telling individuals to make better choices. Public health responses may need to consider food affordability, clinical screening access, culturally relevant nutrition education, and policy design.
Population Averages Can Hide Risk
National averages can improve while specific groups still face nutritional concerns. That is one of the most useful lessons from CDC Nutrition Biomarkers. Vitamin D averages increased, yet deficiency changed only minimally. Folate status improved greatly after fortification, yet recent measures in women of reproductive age still showed increases in folate insufficiency. Supplement users may show higher nutrient levels, yet excess vitamin D also increased.
This mixed picture argues against simple wellness messages. Nutrition is not only about deficiency. It is also about excess, access, life stage, and whether public health interventions reach the people most likely to benefit.
Practical Questions About CDC Nutrition Biomarkers
What Readers Can Discuss With A Clinician
For individuals, the most useful response is not self-diagnosis. A reader who is concerned about nutrient status can ask a qualified clinician whether personal risk factors make testing, dietary counseling, or supplement review appropriate. Useful discussion points may include pregnancy planning, heavy menstrual bleeding, restrictive eating patterns, gastrointestinal conditions, medication interactions, vegan or vegetarian diets, prior deficiency, and current supplement use.
It may also be reasonable to bring a full supplement list to a healthcare visit, including doses and frequency. This can help a clinician assess whether intake is aligned with personal needs and whether any nutrient could be excessive. The report’s vitamin D excess pattern is a reminder that nutrient status can move in both directions.
How To Read The 2026 Findings
CDC Nutrition Biomarkers should be read as a careful public health measurement effort, not as a wellness checklist. The findings point to progress in some areas, ongoing shortfalls in others, and disparities that deserve attention. They also show why nutrition policy, clinical care, and personal choices intersect but are not interchangeable.
If you have questions about iron, folate, vitamin D, iodine, omega-3 status, or supplement safety, consider discussing your age, health history, diet pattern, medications, pregnancy status, and current supplement use with a qualified healthcare professional. That conversation can place population findings into the context that personal health decisions require.
